Marc Buyse

1983–2025 年に発表

155
論文数
42,083
被引用数
98
h 指数
152
i10 指数

被引用数

Marc Buyse の年別被引用数1984 年: 被引用 2 件1985 年: 被引用 4 件1986 年: 被引用 2 件1987 年: 被引用 8 件1988 年: 被引用 12 件1989 年: 被引用 16 件1990 年: 被引用 33 件1991 年: 被引用 24 件1992 年: 被引用 29 件1993 年: 被引用 41 件1994 年: 被引用 37 件1995 年: 被引用 50 件1996 年: 被引用 42 件1997 年: 被引用 61 件1998 年: 被引用 73 件1999 年: 被引用 89 件2000 年: 被引用 107 件2001 年: 被引用 96 件2002 年: 被引用 151 件2003 年: 被引用 97 件2004 年: 被引用 136 件2005 年: 被引用 167 件2006 年: 被引用 177 件2007 年: 被引用 253 件2008 年: 被引用 359 件2009 年: 被引用 408 件2010 年: 被引用 468 件2011 年: 被引用 438 件2012 年: 被引用 415 件2013 年: 被引用 394 件2014 年: 被引用 407 件2015 年: 被引用 372 件2016 年: 被引用 325 件2017 年: 被引用 339 件2018 年: 被引用 259 件2019 年: 被引用 913 件2020 年: 被引用 861 件2021 年: 被引用 824 件2022 年: 被引用 642 件2023 年: 被引用 435 件2024 年: 被引用 682 件2025 年: 被引用 311 件2026 年: 被引用 12 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,642 件、この内訳の 23.7%イギリス: 引用元論文 1,280 件、この内訳の 8.3%中国: 引用元論文 969 件、この内訳の 6.3%イタリア: 引用元論文 946 件、この内訳の 6.1%ドイツ: 引用元論文 834 件、この内訳の 5.4%フランス: 引用元論文 808 件、この内訳の 5.3%カナダ: 引用元論文 641 件、この内訳の 4.2%ベルギー: 引用元論文 573 件、この内訳の 3.7%オランダ: 引用元論文 533 件、この内訳の 3.5%日本: 引用元論文 486 件、この内訳の 3.2%スペイン: 引用元論文 479 件、この内訳の 3.1%オーストラリア: 引用元論文 458 件、この内訳の 3%
0%23.7%その他 24.2%

分野

  • Medicine63.4%
  • Biochemistry, Genetics and Molecular Biology25.9%
  • Mathematics1.8%
  • Immunology and Microbiology1.8%
  • Computer Science1.6%
  • Economics, Econometrics and Finance1%
  • その他4.5%

トピック

  • Breast Cancer Treatment Studies4.7%
  • HER2/EGFR in Cancer Research4.7%
  • Colorectal Cancer Treatments and Studies4.3%
  • Colorectal Cancer Surgical Treatments3%
  • Cancer Treatment and Pharmacology2.6%
  • Cancer Genomics and Diagnostics2.5%
  • その他78.2%

共著者

全論文

検索で開く
  1. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 2,775

  2. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 434

  3. Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 676

  4. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 621

  5. Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

    著者: , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2006 被引用: 2,127

  6. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Feng Xu, Alan Auerbach, Marc Buyse, Arlene Chan, Vernon Harvey, Rudolf Tomek, Nicholas J. Robert, Ira Gore, John W. Smith, Norikazu Masuda, S. Di Sean Kendall, William Graydon Harker, Katarína Petráková, Ángel Guerrero‐Zotano, Amparo Ruiz Simón, Zora Neskovic Konstantinovic, Nicholas Iannotti, Pierfrancesco Tassone, Gladys Rodriguez, Noelia Jáñez Martínez, Carmen Crespo Massieu, Snezana Smickoska, Işıl Somali, Uğur Yılmaz, Mirta Garcia Alonso, Adolfo Rosales, Soeren Cold, Ann Knoop, Debra A. Patt, Beth A. Hellerstedt, Serafin Morales Murillo, Ingrid A. Mayer, Julie A. Means‐Powell, Rina Hui, Francis M. Senecal, Richard Hendry De Boer, Zhenzhou Shen, A.A. Luczak, Joanna W.Y. Chui, Janice Tsang, István Láng, Yoshiaki Rai, Yasuo Hozumi, Albert J. ten Tije, Manish Bhandari, Cynthia R. Osborne, Shoichiro Ohtani, Kenji Higaki, Kenichi Watanabe, Kazunori TAGUCHI, Masato Takahashi, Sladjana Filipovic, Vincent Hansen, Vijayarama Phooshkooru Rao, Manish Gupta, Petar Petrov, Bruno Coudert, Željko Vojnović, Zsofia Polya, Toshiko Miyaki, Naohito Yamamoto, Stephen Brincat, Krzysztof Leśniewski-Kmak, Ewa Chmielowska, Ruemu Birhiray, Marc L. Citron, Steven W. Papish, William L. Berry, Sven Tyge Langkjer, José Á. García-Sáenz ほか 526 名 - The Lancet Oncology 2017 被引用: 589

  7. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2021 被引用: 244

  8. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2003 被引用: 2,920

  9. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 565

  10. Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 96

  11. The validation of surrogate endpoints in meta-analyses of randomized experiments

    著者: , , , , - Biostatistics 2000 被引用: 605

  12. Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

    著者: , , , , , , , , - Clinical Cancer Research 2008 被引用: 842

  13. A Phase III Open-Label Trial to Evaluate Efficacy and Safety of CPI-613 Plus Modified FOLFIRINOX (MFFX) versus FOLFIRINOX (FFX) in Patients with Metastatic Adenocarcinoma of the Pancreas

    著者: , , , , , , - Future Oncology 2019 被引用: 99

  14. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases

    著者: , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 1997 被引用: 1,535

  15. Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials

    著者: , , , , , , , , - JNCI Journal of the National Cancer Institute 2007 被引用: 378

  16. Common pitfalls in statistical analysis: The perils of multiple testing

    著者: , , - Perspectives in Clinical Research 2016 被引用: 207

  17. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 306

  18. Outcome measures in multimodal rectal cancer trials

    著者: , , , , , , , , , , , , , , , - The Lancet Oncology 2020 被引用: 104

  19. A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Irit Rosenblatt, Alexander Rubowitz, Oren Tomkins Netzer, Francesco Bandello, Antonio Ciardella, Federico Ricci, Giovanni Staurenghi, Gianni Virgili, Kristine Baumane, Guna Laganovska, Signe Ozolina, Ilze Strautmane, Bartlomiej Kaluzny, Jerzy Mackiewicz, Marta Misiuk-Hoilo, Ewa Mrukwa-Kominek, Piotr Oleksy, Krystyna Raczynska, Tomasz Zarnowski, Alfredo Adan, Javier Araiz, Anna Boixadera, Alvaro Fernández-Vega, Alfredo Garcia Layana, Francisco Gomez-Ulla, Javier Montero, Jose Maria Ruiz Moreno, David Gilmour, Timothy Jackson, Timothy Jackson, Sidath Liyanage, Luke Membrey, Geeta Menon, Niro Narendran, Sobha Sivaprasad, Daniel Alfaro, Andrew Antoszyk, Carl Baker, Ivan Batille, Brian Berger, David Boyer, William Bridges, Harold Brooks, David Brown, Margaret Chang, Daniel Chao, Sanford Chen, Courtney Crawford, Pravin Dugel, Alexander Eaton, David Eichenbaum, Jordana Fein, Leonard Feiner, Christina Flaxel, Frank Garber, Alan Gordon, Sunil Gupta, Curtis Haegedorn, George Hampton, Thomas Hanscom, Vrinda Hershberger, Peter Kaiser, Randy Katz, Arshad Khanani, Erik Kruger, Denis Marcus, Matthew Ohr, Sunil Patel, Joel Pearlman, Richard Pesavento ほか 21 名 - Ophthalmology 2023 被引用: 50

  20. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 815

  21. Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 被引用: 712

  22. Common pitfalls in statistical analysis: Clinical versus statistical significance

    著者: , , - Perspectives in Clinical Research 2015 被引用: 264

  23. Surrogate threshold effect: an alternative measure for meta‐analytic surrogate endpoint validation

    著者: , - Pharmaceutical Statistics 2006 被引用: 201

  24. Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 265